Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioVie Inc. - Common stock (NQ: BIVI )

1.040 +0.020 (+1.97%)
Streaming Delayed Price Updated: 11:05 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioVie Inc. - Common stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 6/12
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/30
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/25
Via Investor Brand Network
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
Via Benzinga
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/17
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 5/8
Via Investor Brand Network
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million... 
Via Benzinga
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate. 
Via Talk Markets
BioVie's Lead Drug Candidate Aims To Treat Neurodegenerative Disease By Targeting Inflammation
Via ACCESSWIRE
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 4/25
Via Investor Brand Network
BioVie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 4/19
Via Investor Brand Network
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/22
Via Investor Brand Network
Top 5 Health Care Stocks That May Explode In Q3
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
BioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Friday, April 28, 2023: COST, SOFI, COIN, NET, BIVI
Costco Wholesale (COST) - The company will report monthly sales results for April on Wednesday of next week. This has been a news catalyst for Costco over the last few years -- albeit a modest 
Via Benzinga
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/17
Via Investor Brand Network
Biovie Inc. (NASDAQ: BIVI) is a Stock Spotlight on 3/16
Via Investor Brand Network
BioVie Says Its Parkinson's Candidate Eases Morning 'Rigid Muscles'
Via Benzinga
BioVie Inc. and iRemedy Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Why Shares of BioVie Jumped This Week
BioVie's announcement regarding a phase 2 trial for its lead therapy helped raise the stock's price. 
Via The Motley Fool
Why Shares of BioVie Jumped 51.7% in February
The company is forging ahead with a phase 3 trial for its lead therapy. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
Via ACCESSWIRE
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.